NCT06873516Phase 2Completed

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

Study sponsor: Evommune, Inc. · EVMN

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-05-29Actual
Enrollment · participants182Actual
Source updated2026-07-01Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 5 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

160 participants (planned)

+ After

182 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Jun 2026

+ After

29 May 2026

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source

· 1 field changed

Primary completion date changed

− Before

May 2026

+ After

Jun 2026

Check registry source

· 1 field changed

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source